Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intervention Development for Anxiety in Metastatic NSCLC Patients and Their Caregivers

NCT01729689 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01729689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01729689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intervention Development for Anxiety in Metastatic NSCLC Patients and Their Caregivers
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2012
Completion date
November 30, 2013
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorder, recurrent non-small cell lung cancer, stage iv non-small cell lung cancer